JENSEN FLEMMING STEEN

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
JENSEN FLEMMING STEEN's trades of Ascendis Pharma A/S's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-12 2026-05-11 S Sale
39,295 +13.8%
132.86
US$4,668,757
39,295 +13.8% 132.86 US$4,668,757
2026-05-11 2026-05-11 PrS Proposed sale
31,730
274.58
US$1,450,290
31,730 274.58 US$1,450,290
2026-03-02 2026-03-02 PrS Proposed sale
6,266
332.32
US$1,907,719
6,266 332.32 US$1,907,719
2025-12-02 2025-12-02 PrS Proposed sale
10,000
205.85
US$2,058,454
10,000 205.85 US$2,058,454
2025-09-09 2025-09-09 PrS Proposed sale
5,000
203.70
US$1,018,503
5,000 203.70 US$1,018,503
2025-08-13 2025-08-13 PrS Proposed sale
10,000
191.32
US$1,913,225
10,000 191.32 US$1,913,225
2025-05-07 2025-05-07 PrS Proposed sale
10,938
162.20
US$1,774,164
10,938 162.20 US$1,774,164
2025-03-06 2025-03-06 PrS Proposed sale
10,000
152.39
US$1,523,933
10,000 152.39 US$1,523,933
2025-03-04 2025-03-04 PrS Proposed sale
7,719
152.12
US$1,174,249
7,719 152.12 US$1,174,249
2025-02-18 2025-02-18 PrS Proposed sale
10,000
146.80
US$1,467,977
10,000 146.80 US$1,467,977
2024-12-10 2024-12-10 PrS Proposed sale
1,222
129.13
US$157,794
1,222 129.13 US$157,794
2024-12-03 2024-12-03 PrS Proposed sale
9,375
131.37
US$1,231,574
9,375 131.37 US$1,231,574
2024-03-05 2024-03-01 PrS Proposed sale
3,892
150.00
US$583,800
3,892 150.00 US$583,800
2024-02-16 2024-02-16 PrS Proposed sale
4,687
148.22
US$694,709
4,687 148.22 US$694,709
2023-09-15 2023-09-15 PrS Proposed sale
6,500
102.74
US$667,827
6,500 102.74 US$667,827